DNA Ginkgo Bioworks Corp.: חוב לטווח קצר להון

Ginkgo Bioworks Holdings (DNA) is implementing cloud access to biological engineering, erasing geographical boundaries for researchers. The business automates the creation of cellular code via AI, utilizing external server capacities to optimize expenses. Horizontal market reach, spanning from the agricultural sector to chemicals, minimizes industry-specific risks. This price chart for Ginkgo Bioworks Holdings (DNA) on GURU.Markets demonstrates the 0.00 metric, confirming the resilience of this development model.

This indicator measures the proportion of short-term liabilities relative to equity, allowing for an assessment of liquidity risk and the company's resilience to a sharp cooling of demand. The current ratio of short-term debt to equity stands at 0.00, which is critically important for Ginkgo Bioworks Holdings (DNA), given that their business model depends on external cloud computing and partner outsourcing for laboratory research.